Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ellen L Goode

Showing results (161-170 of 315) with videos related to

Pageof 32
Sort By:
Human Genetics|November 4, 2024
Germline copy number variants and endometrial cancer riskCassie E Stylianou, George A R Wiggins, Vanessa L Lau, et al.
Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2011
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association ConsortiumJennifer Permuth-Wey, Zhihua Chen, Ya-Yu Tsai, et al.
Nature Genetics|December 1, 2022
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancerDale W Garsed, Ahwan Pandey, Sian Fereday, et al.
Oncotarget|September 9, 2017
Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility geneEd Dicks, Honglin Song, Susan J Ramus, et al.
Plos One|February 6, 2013
Inherited variants in regulatory T cell genes and outcome of ovarian cancerEllen L Goode, Melissa DeRycke, Kimberly R Kalli, et al.
JCO Oncology Advances|April 1, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark AnalysisLuigi A De Vitis, Melissa C Larson, Hunter J Atkinson, et al.
Journal of the National Cancer Institute|August 29, 2015
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J Ramus, Honglin Song, Ed Dicks, et al.
American Journal of Epidemiology|May 22, 2024
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association ConsortiumNicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Cancer Research|April 6, 2007
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancerSimon A Gayther, Honglin Song, Susan J Ramus, et al.
Pageof 32

Showing results (161-170 of 315) with videos related to

Sort By:
Pageof 32
Human Genetics|November 4, 2024
Germline copy number variants and endometrial cancer riskCassie E Stylianou, George A R Wiggins, Vanessa L Lau, et al.
Journal of the National Cancer Institute|February 8, 2014
Aspirin, nonaspirin nonsteroidal anti-inflammatory drug, and acetaminophen use and risk of invasive epithelial ovarian cancer: a pooled analysis in the Ovarian Cancer Association ConsortiumBritton Trabert, Roberta B Ness, Wei-Hsuan Lo-Ciganic, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|June 4, 2011
MicroRNA processing and binding site polymorphisms are not replicated in the Ovarian Cancer Association ConsortiumJennifer Permuth-Wey, Zhihua Chen, Ya-Yu Tsai, et al.
Nature Genetics|December 1, 2022
The genomic and immune landscape of long-term survivors of high-grade serous ovarian cancerDale W Garsed, Ahwan Pandey, Sian Fereday, et al.
Oncotarget|September 9, 2017
Germline whole exome sequencing and large-scale replication identifies <i>FANCM</i> as a likely high grade serous ovarian cancer susceptibility geneEd Dicks, Honglin Song, Susan J Ramus, et al.
Plos One|February 6, 2013
Inherited variants in regulatory T cell genes and outcome of ovarian cancerEllen L Goode, Melissa DeRycke, Kimberly R Kalli, et al.
JCO Oncology Advances|April 1, 2026
Long-Term Survival in High-Grade Serous Ovarian Cancer Compared With the General US Population: A 30-Year Landmark AnalysisLuigi A De Vitis, Melissa C Larson, Hunter J Atkinson, et al.
Journal of the National Cancer Institute|August 29, 2015
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J Ramus, Honglin Song, Ed Dicks, et al.
American Journal of Epidemiology|May 22, 2024
Racial and ethnic differences in epithelial ovarian cancer risk: an analysis from the Ovarian Cancer Association ConsortiumNicola S Meagher, Kami K White, Lynne R Wilkens, et al.
Cancer Research|April 6, 2007
Tagging single nucleotide polymorphisms in cell cycle control genes and susceptibility to invasive epithelial ovarian cancerSimon A Gayther, Honglin Song, Susan J Ramus, et al.
Pageof 32